Cargando…
How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy
Mounting an immune response sufficient to eradicate a tumor is the goal of modern immunotherapy. Single agent therapies with checkpoint inhibitors or costimulatory molecule agonists are effective only for a small portion of all treated patients. Combined therapy, e.g., CTLA-4 and PD-1 checkpoint blo...
Autores principales: | Linch, Stefanie N., Redmond, William L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915175/ https://www.ncbi.nlm.nih.gov/pubmed/27330804 http://dx.doi.org/10.1186/s40425-016-0135-z |
Ejemplares similares
-
Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells
por: Redmond, William L., et al.
Publicado: (2016) -
Curriculum reform: the more things change, the more they stay the same?
por: Hawick, Lorraine, et al.
Publicado: (2016) -
Combined OX40 ligation plus CTLA-4 blockade: More than the sum of its parts
por: Linch, Stefanie N, et al.
Publicado: (2014) -
Heated tobacco products: things we do and do not know
por: Stepanov, Irina, et al.
Publicado: (2018) -
Can fuzzy logic make things more clear?
por: Hazelzet, Jan A
Publicado: (2009)